BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin SD, McGee SL. Metabolic reprogramming in type 2 diabetes and the development of breast cancer. J Endocrinol 2018;237:R35-46. [PMID: 29487204 DOI: 10.1530/JOE-18-0037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Silva C, Andrade N, Guimarães JT, Cardoso E, Meireles C, Pinto V, Paiva J, Martel F. The pro-proliferative effect of insulin in human breast epithelial DMBA-transformed and non-transformed cell lines is PI3K-, mTOR- and GLUT1-dependent. Cell Biochem Funct 2022. [PMID: 35014047 DOI: 10.1002/cbf.3681] [Reference Citation Analysis]
2 Cheng J, Chen T, Chen T, Ku H, Huang S, Wu T, Chien R, Chang M. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.02.009] [Reference Citation Analysis]
3 Mikó E, Kovács T, Sebő É, Tóth J, Csonka T, Ujlaki G, Sipos A, Szabó J, Méhes G, Bai P. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells 2019;8:E293. [PMID: 30934972 DOI: 10.3390/cells8040293] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
4 Lempesis IG, van Meijel RLJ, Manolopoulos KN, Goossens GH. Oxygenation of adipose tissue: A human perspective. Acta Physiol (Oxf) 2020;228:e13298. [PMID: 31077538 DOI: 10.1111/apha.13298] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
5 Rachfal AW, Grant SFA, Schwartz SS. The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. Int J Gen Med 2021;14:923-36. [PMID: 33776471 DOI: 10.2147/IJGM.S305156] [Reference Citation Analysis]
6 Jing W, Li L, Zhang X, Wu S, Zhao J, Hou Q, Wu H, Ma W, Li S, Liu H, Yang B. Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease. Transl Oncol 2020;13:245-53. [PMID: 31869749 DOI: 10.1016/j.tranon.2019.09.008] [Reference Citation Analysis]
7 Durrani IA, Bhatti A, John P. The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxia-hyperglycemia axis. Cancer Cell Int 2021;21:351. [PMID: 34225729 DOI: 10.1186/s12935-021-02040-5] [Reference Citation Analysis]
8 Yan X, Gao Z, Zhou Y, Gao F, Li Q. Expressions of IGF-1R and Ki-67 in breast cancer patients with diabetes mellitus and an analysis of biological characteristics. Pak J Med Sci 2022;38:281-6. [PMID: 35035440 DOI: 10.12669/pjms.38.1.4718] [Reference Citation Analysis]